127 results
Page 3 of 7
8-K
EX-99.1
xyzjgr kdoo85os0zp
6 Nov 19
Aptose to Present New CG-806 Data at the 2019 ASH Annual Meeting
10:07am
424B5
kwciyf7m
30 May 19
Prospectus supplement for primary offering
4:11pm
424B5
n2iv3wkpjd fu4ci8oeh
29 May 19
Prospectus supplement for primary offering
5:02pm
10-Q
keiv2r xwb0vp6nce6n
7 May 19
Quarterly report
4:47pm
10-K
lia dmmjzc
12 Mar 19
Annual report
4:57pm
6-K
EX-99.1
inhhqf13 bwt
12 Dec 18
Aptose Presents Highlights From CG-806 KOL Event
10:00am
6-K
EX-99.1
w5zn1ccgn2edxur7 ev
3 Dec 18
OHSU and Aptose Present New CG-806 Preclinical Data at ASH 60th Annual Meeting
7:10am
6-K
EX-99.1
0hmnzmoy401ek2o
3 Dec 18
Aptose Presents New Preclinical Data on CG-806 PAN-FLT3/PAN-BTK Inhibitor at ASH 60th Annual Meeting
7:05am
6-K
EX-99.1
bgtfw71c24k0dwrl1
20 Nov 18
Aptose to Participate in Upcoming Investor Conferences, Host Key Opinion Leader Event, and Present Data at the Upcoming ASH Meeting
7:05am
6-K
EX-99.2
zewqvux1afv8xq5g
6 Nov 18
Condensed Consolidated Interim Statements of Financial Position
5:14pm
6-K
EX-99.1
mj9t3q8
1 Nov 18
Aptose to Present New CG-806 Data at the 2018 ASH Annual Meeting
9:37am
6-K
EX-99.2
emjly8m mk61
7 Aug 18
Condensed Consolidated Interim Statements of Financial Position
5:17pm
6-K
EX-99.1
d48en
9 Jul 18
Current report (foreign)
1:59pm
SUPPL
v4qbh08x32s
8 Jun 18
Supplemental materials (foreign)
2:07pm
6-K
EX-99.2
sjwlg9l1xst
10 May 18
Condensed Consolidated Interim Statements of Financial Position
5:05pm
424B3
0nuuafog
13 Apr 18
Prospectus supplement
12:00am